Addex Therapeutics Ltd. Sponsored ADR (ADXN) vs GeoVax Labs Inc. (GOVX)

Addex Therapeutics Ltd. Sponsored ADR and GeoVax Labs Inc. are both Biotechnology companies. Addex Therapeutics Ltd. Sponsored ADR and GeoVax Labs Inc. are of similar size ($3.7M and $3.6M). GeoVax Labs Inc. grew revenue faster over the last twelve months: 963.6% against −89.4%. Across the 13 metrics below, GeoVax Labs Inc. leads on 8 and Addex Therapeutics Ltd. Sponsored ADR on 5.

Valuation

Metric ADXN GOVX Biotechnology median
P/E n/m n/m 7.88
P/S 35.78 0.26 11.47
P/B 0.86 0.91 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.07 0.74
EV/Sales 23.94 (0.22) 10.73
Earnings yield (261.24%) (1,715.69%) (28.84%)
Free cash flow yield (81.40%) (1,151.45%) (23.03%)

Profitability

Metric ADXN GOVX Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (129.15%) (891.59%) (57.72%)
Return on assets (104.27%) (408.79%) (49.22%)
Return on invested capital (69.46%) 0.00% 0.00%

Growth

Metric ADXN GOVX Biotechnology median
Revenue growth (TTM) (89.37%) 963.56% 5.64%
EPS growth (last fiscal year) (191.09%) 81.41% —
Revenue growth, 5-year CAGR (60.68%) 16.18% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADXN GOVX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.97 1.54 4.73
Net debt to EBITDA 0.58 0.14 0.96

Dividend

Metric ADXN GOVX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ADXN GOVX Biotechnology median
Market cap 3.64m 3.67m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack